Concepedia

Pamela Hill

PH

Statistics

Publications

9

Citations

466

H-Index

9

Active since

2008

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (Sweden)

AstraZeneca (United Kingdom)

Pamela Hill is an author at AstraZeneca (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2008–2022

9

Publications

9

Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy

Brian Sherer, Kenneth G. Hull, Oluyinka Green et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 121 citations · Full text

, , +14

Optimization of Pyrrolamide Topoisomerase II Inhibitors Toward Identification of an Antibacterial Clinical Candidate (AZD5099)

Gregory S. Basarab, Pamela Hill, C. Edwin Garner et al. · Journal of Medicinal Chemistry · 2014 · 81 citations · Full text

, , +17

DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets

Arwa Bin Raies, Ewa Tulodziecka, James Stainer et al. · Communications Biology · 2022 · 60 citations · Full text

, , +13

Selective Inhibitors of Bacterial t-RNA-(N<sup>1</sup>G37) Methyltransferase (TrmD) That Demonstrate Novel Ordering of the Lid Domain

Pamela Hill, Ayome Abibi, Robert Albert et al. · Journal of Medicinal Chemistry · 2013 · 55 citations

, , +12

Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): Pyridodiazepine amines

Bolin Geng, Gregory S. Basarab, Janelle Comita-Prevoir et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 50 citations · Full text

, , +9

1–5 of 9